KENILWORTH, N.J. & NEW YORK–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, in partnership with Pfizer Inc. (NYSE:PFE), today announced that two Phase 3 studies (VERTIS MET and VERTIS SITA) of ertugliflozin, an investigational oral SGLT-2 inhibitor in development to help improve glycemic control in adults …
Tag Archives: American Diabetes Association
June, 2017
February, 2016
-
12 February
New Staging Classification for Type 1 Diabetes Opens Door for Intervention
SEATTLE, Feb. 12, 2016 /PRNewswire/ — For most people, the onset of type 1 diabetes seems to occur suddenly, often resulting in a trip to the emergency room with life-threatening complications such as diabetic ketoacidosis (DKA). TrialNet is a worldwide leader in type 1 diabetes prevention research and one of the …